Thiopentone and ketamine versus isoflurane and fentanyl to maintain anaesthesia during cardiopulmonary bypass; effect on postoperative neuropsychological function. Neuropsychological Function after Coronary Artery Bypass Graft (CABG)

ISRCTN ISRCTN89332886
DOI https://doi.org/10.1186/ISRCTN89332886
Protocol serial number N0054119938
Sponsor Department of Health (UK)
Funder The Cardiothoracic Centre Liverpool NHS Trust (UK)
Submission date
12/09/2003
Registration date
12/09/2003
Last edited
05/12/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr J Murphy
Scientific

Department of Anaesthesia
The Cardiothoracic Centre
Liverpool NHS Trust
Thomas Drive
Liverpool
L14 3PE
United Kingdom

Phone +44 (0)151 228 1616
Email abc@email.com

Study information

Primary study designInterventional
Study designProspective randomised double-blind study
Secondary study designRandomised controlled trial
Scientific titleThiopentone and ketamine versus isoflurane and fentanyl to maintain anaesthesia during cardiopulmonary bypass; effect on postoperative neuropsychological function. Neuropsychological Function after Coronary Artery Bypass Graft (CABG)
Study objectivesTo compare neurophysiological function after maintaining anaesthesia for cardiopulmonary bypass (CPB) with either:
1.Thiopentone and ketamine, or
2. Isoflurane and fentanyl
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedSurgery: Anaesthesia
InterventionOnly the anaesthetist will be aware of which treatment is being given but they will not be involved in gathering the primary outcome data. Patients will undergo standard neuropsychological assessments and neurological examinations before and after surgery.

Thiopentone and ketamine preserve neuropsychological function after CABG when compared to standard technique.
Intervention typeDrug
PhaseNot Applicable
Drug / device / biological / vaccine name(s)Thiopentone and ketamine versus isoflurane and fentanyl
Primary outcome measure(s)

Assessment of neurological outcome, mood, personality and quality of life and correlations with any change in neuropsychological function will be made.

Key secondary outcome measure(s)

Not provided at time of registration

Completion date01/03/2004

Eligibility

Participant type(s)Patient
Age groupAdult
SexAll
Key inclusion criteria1. All patients scheduled for elective CABG under the care of two surgical/anaesthetic teams
2. Under 80 years of age
3. Do not have porphyria, severe unstable coronary artery disease (UCAD) or who have hypersensitivity to any of the study drugs or central nervous system (CNS) disease.
Key exclusion criteriaNot provided at time of registration
Date of first enrolment18/10/2002
Date of final enrolment01/03/2004

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Liverpool NHS Trust
Liverpool
L14 3PE
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan